Who are Zhaveri Pharmakem?
Zhaveri Pharmakem is Crescent Pharmaceutical Group's dedicated EU GMP approved pharmaceutical development and manufacturing facility, providing integrated research, development, technical transfer and commercial manufacturing capabilities.
As one of the Group's key strategic investments, the site plays a central role in accelerating new product development, expanding the product portfolio and supporting Crescent Pharma's long-term commitment to delivering high-quality, affordable medicines to patients worldwide.
Working in close collaboration with Crescent Pharma's UK regulatory, technical and commercial teams, Zhaveri Pharmakem provides an efficient pathway from product concept through development, validation, technical transfer and commercial manufacture. This integrated approach enables faster development timelines, enhanced technical expertise and a resilient global supply chain.
The facility supports a broad range of pharmaceutical activities including:
- Pharmaceutical formulation and product development
- Analytical method development and validation
- Technical transfer and scale-up
- Process optimisation
- Stability studies
- Commercial manufacturing
- Regulatory support for global product registrations
As part of Crescent Pharmaceutical Group’s international manufacturing and development network, Zhaveri Pharmakem strengthens the Group’s vertically integrated capabilities, helping to accelerate more than 100 new product launches annually while supporting the Group’s ambition to exceed 1,000 product lines by 2030.
Together with Crescent Pharma’s UK manufacturing facilities and global supply partners, Zhaveri Pharmakem provides the technical expertise, development capability and manufacturing capacity required to deliver innovative, high-quality generic medicines to regulated markets around the world.